1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KRT78 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA OTOP2 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA PIK3R2 CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA GRHL2 CTRPv2 pan-cancer AAC 0.18 0.0001
mRNA CDH1 CTRPv2 pan-cancer AAC 0.17 0.0001
mRNA HERPUD2 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA CTDSPL CTRPv2 pan-cancer AAC 0.17 0.0001
mRNA CTB-50L17.10 CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA TAX1BP1 CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA CELF1 CTRPv2 pan-cancer AAC -0.14 0.0002
Download CSV